Russell Investments Group, Ltd. Athersys, Inc Transaction History

Russell Investments Group, Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$0.85 - $1.4 $12,228 - $20,140	-14,386 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$1.41 - $1.94 $960,596 - $1.32 Million	-681,274 Reduced 97.93%	14,386 $20,000
Q1 2021 May 10, 2021	SELL	$1.61 - $2.77 $274,759 - $472,722	-170,658 Reduced 19.7%	695,660 $1.25 Million
Q4 2020 Feb 08, 2021	SELL	$1.55 - $2.24 $319,344 - $461,504	-206,029 Reduced 19.21%	866,318 $1.52 Million
Q3 2020 Nov 09, 2020	BUY	$1.91 - $3.08 $1.8 Million - $2.9 Million	940,041 Added 710.51%	1,072,347 $2.09 Million
Q2 2020 Aug 05, 2020	SELL	$1.97 - $3.98 $52,845 - $106,763	-26,825 Reduced 16.86%	132,306 $365,000
Q4 2019 Jan 29, 2020	BUY	$1.16 - $1.42 $26,275 - $32,164	22,651 Added 16.6%	159,131 $195,000
Q3 2019 Nov 01, 2019	BUY	$1.21 - $1.65 $165,140 - $225,192	136,480 New	136,480 $182,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.